Skip to main content

N 343 2.5 Pill - orange round, 8mm

Pill with imprint N 343 2.5 is Orange, Round and has been identified as Glyburide 2.5 mg. It is supplied by Teva Pharmaceuticals USA.

Glyburide is used in the treatment of Type 2 Diabetes and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for N 343 2.5

Glyburide 2.5 mg N 343 2.5
Glyburide 2.5 mg N 343 2.5 Front
Glyburide 2.5 mg N 343 2.5 Back
Glyburide 2.5 mg N 343 2.5 Front
Glyburide 2.5 mg N 343 2.5 Back
Glyburide 2.5 mg N 343 2.5
Glyburide 2.5 mg N 343 2.5

Glyburide

Imprint
N 343 2.5
Strength
2.5 mg
Color
Orange
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
microcrystalline cellulose, corn starch, sodium starch glycolate type A potato, silicon dioxide, magnesium stearate, FD&C Yellow No. 6, aluminum oxide

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-8343 Teva Pharmaceuticals USA, Inc.
42291-0316 AvKare, Inc.
51079-0872 (Discontinued) UDL Laboratories Inc.
35356-0360 (Discontinued) Lake Erie Medical and Surgical Supply (repackager)
55289-0606 PDRX Pharmaceuticals Inc. (repackager)

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.